TABLE 1.
Cohort demographics
Patient | Mutated gene | Sex | Age at last observation (years) | Age at death (years) | Age onset of hip pain-related walking difficulty (years) | Age onset of imaging findings of AVN/hip degeneration (years) | Age bilateral diagnosis of AVN/hip degeneration (years) |
---|---|---|---|---|---|---|---|
Patients with hip degeneration | |||||||
TTD412BE-DNP | ERCC2/XPD | M | 9 | 10a | 5 | 5 | 8 |
TTD405BE-DP | ERCC2/XPD | F | 15 | 6 | 6 | 6 | |
TTD401BE-DNP | ERCC2/XPD | F | 18 | 6 | 9 | 9 | |
TTD354BE-DP | ERCC2/XPD | F | 9 | 9b | 7 | 7 | 9 |
TTD519BE-DP | ERCC2/XPD | M | 15 | 7 | 9 | 9 | |
TTD421BE-DP | ERCC2/XPD | F | 14 | 9 | 11 | Right only | |
TTD462BE-DP | ERCC2/XPD | F | 11 | 10 | 10.5 | Left only | |
TTD355BE-DP | ERCC2/XPD | M | 12 | 12c | 10 | ND | Left only |
TTD351BE-DP | ERCC2/XPD | M | 15 | 15d | 11 | 12 | 14 |
TTD328BE-DMP | ERCC2/XPD | M | 29 | 12 | 13 | 17 | |
Median age 15 | Median age 11 | Median age 8 | Median age 9 | Median age 9 | |||
Range 9–29 | Range 9–15 | Range 5–12 | Range 5–13 | Range 6–17 | |||
Patients without hip degeneration | |||||||
TTD471BE-DNP | ERCC2/XPD | M | 2 | 2e | |||
TTD496BE-DMP | ERCC2/XPD | M | 2 | ||||
TTD445BE-DNP | ERCC2/XPD | M | 3 | 3f | |||
TTD472BE-DP | ERCC2/XPD | M | 3 | 3g | |||
TTD568BE-DNP | ERCC2/XPD | F | 4 | ||||
TTD383BE-DMP | ERCC2/XPD | F | 7 | 7h | |||
TTD475BE-DNP | ERCC2/XPD | M | 8 | ||||
TTD397BE-DNP | ERCC2/XPD | M | 13 | ||||
TTD409BE-DNP | ERCC2/XPD | M | 13 | ||||
TTD506BE-DMP | ERCC2/XPD | M | 15 | ||||
TTD353BE-DNP | ERCC2/XPD | F | 17 | ||||
TTD378BE-DP | ERCC2/XPD | F | 18 | ||||
TTD352BE-DNP | ERCC2/XPD | F | 19 | ||||
Median age 8 | Median age 3 | ||||||
Range 2–19 | Range 2–19 | ||||||
TTD402BE-NNP | MPLKIP/TTDN1 | M | 23 | ||||
TTD480BE-NNP | MPLKIP/TTDN1 | F | 12 | ||||
TTD488BE-NNP | MPLKIP/TTDN1 | F | 9 | ||||
TTD343BE-NP | MPLKIP/TTDN1 | M | 30 | ||||
TTD487BE-NNP | MPLKIP/TTDN1 | M | 7 | ||||
Median age 12 | |||||||
Range 7–30 | |||||||
TTD403BE-AP | GTF2H5/TTDA | F | 29 | ||||
TTD332BE-AMP | GTF2H5/TTDA | M | 36 | 36i | |||
TTD331BE-AP | GTF2H5/TTDA | M | 27 | ||||
Median age 29 | |||||||
Range 27–36 | |||||||
TTD379BE-GNP | GTF2E2 | M | 10 | ||||
Median age N/A | |||||||
Range N/A | |||||||
TTD491BE-UMP | Unknown | F | 9 | ||||
TTD125BE-UNP | Unknown | F | 19 | ||||
TTD347BE-Up | Unknown | F | 9 | 9j | |||
TTD484BE-Up | Unknown | F | 11 | ||||
TTD124BE-UNP | Unknown | M | 24 | ||||
Median age 11 | |||||||
Range 9–24 |
Abbreviations: AVN, avascular necrosis; MP, mild photosensitive; NP, nonphotosensitive; P, photosensitive.
Died of sepsis and respiratory arrest after prolonged hospitalization following hip tendon release surgery.
Died 2 years after onset of hip pain due to methicillin-resistant S. aureus pneumonia.
Died after being found unresponsive after dose of methadone.
Died of respiratory failure and sepsis during recovery from hip surgery.
After laparoscopic G-tube placement and fundoplication, he rapidly developed respiratory insufficiency and was unable to be recusicated.
Died at age 3 years of multiple organ failure after long (4–5 months) illness and NICU treatment following dental surgery.
Died at age 3 years after G-tube placement. While inpatient, he became unresponsive, developed respiratory failure, and was unable to be recuscitated.
Died 2006.
Died while hospitalized with pneumonia possibly from cardiogenic shock.
While hospitalized to rule out sepsis, she developed respiratory difficulty. Died of cardiac arrest while attempting intubation.